Related references
Note: Only part of the references are listed.Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study
Severine Huber et al.
BJU INTERNATIONAL (2012)
Influence of Renal Excretory Function on the Performance of Urine Based Markers to Detect Bladder Cancer
Tilman Todenhoefer et al.
JOURNAL OF UROLOGY (2012)
Influence of Urinary Tract Instrumentation and Inflammation on the Performance of Urine Markers for the Detection of Bladder Cancer
Tilman Todenhoefer et al.
UROLOGY (2012)
Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection
Yair Lotan et al.
BJU INTERNATIONAL (2008)
A human protein atlas for normal and cancer tissues based on antibody proteomics
M Uhlén et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Urine markers for bladder cancer surveillance: A systematic review
BWG van Rhijn et al.
EUROPEAN UROLOGY (2005)
Detection of bladder cancer using a point-of-care proteomic assay
HB Grossman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
False-positive results of the NMP22 test due to hematuria
N Atsü et al.
JOURNAL OF UROLOGY (2002)
Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence
H Boman et al.
JOURNAL OF UROLOGY (2002)
The BTA STAT test is nonspecific for hematuria: An experimental hematuria model
O Oge et al.
JOURNAL OF UROLOGY (2002)
Share Paper
